Inicio › Leucemia mielógena aguda › Misisipi
Ensayos clínicos de Leucemia mielógena aguda en Misisipi
8 estudios sobre Leucemia mielógena aguda buscan participantes en Misisipi.
Ciudades en Misisipi
Texto oficial del estudio (inglés)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- y 2 más
ReclutandoFase 2
Edades de 18 a 59 · Todos los sexos · Actualizado el 28 sept 2026 · NCT05554393MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- y 2 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT05564390Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- y 2 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06317649Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- y 2 más
ReclutandoFase 2
Edades de 18 a 59 · Todos los sexos · Actualizado el 22 sept 2026 · NCT05554406A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- University of Mississippi Medical Center, Jackson
ReclutandoFase 3
6 Months – 21 Years · Todos los sexos · Actualizado el 17 sept 2026 · NCT04293562The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- University of Mississippi Medical Center, Jackson
ReclutandoFase 1/2
Hasta los 22 · Todos los sexos · Actualizado el 25 ago 2026 · NCT04726241Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
- University of Mississippi Medical Center, Jackson
ReclutandoFase 3
29 Days – 21 Years · Todos los sexos · Actualizado el 24 ago 2026 · NCT05183035A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Univeristy of Mississippi Medical Center, Jackson
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.